Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs, today announced that management will present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference to be held in New York, NY on December 12.
WARREN, N.J., /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs, today announced that management will present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference to be held in New York, NY on December 12. Aquestive will present on Wednesday, December 12 at 10:40 a.m. Eastern Time. A webcast of the presentation will be available on the “Investors” section of the Investor Relations page on our website. For more information, please visit investors.aquestive.com. About Aquestive Therapeutics Media inquiries: Investor inquiries: View original content to download multimedia:http://www.prnewswire.com/news-releases/aquestive-therapeutics-to-present-at-the-bmo-capital-markets-2018-prescriptions-for-success-healthcare-conference-300761690.html SOURCE Aquestive Therapeutics, Inc. | ||
Company Codes: NASDAQ-NMS:AQST |